Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ruppia maritima extract is an aqueous preparation derived from the shoots of the submerged aquatic plant *Ruppia maritima*, commonly known as Widgeon Grass. This extract is characterized by a rich composition of secondary metabolites, including phenols, flavonoids, tannins, saponins, alkaloids, and steroids. In preclinical in vitro studies, the extract has demonstrated potent antioxidant, antiparasitic, antibacterial, and antineoplastic activities. Its anticancer mechanism of action involves the induction of apoptosis through the disruption of mitochondrial membrane potential, the release of cytochrome c into the cytosol, and the promotion of DNA damage and nuclear condensation. Additionally, it exhibits antibacterial properties by increasing plasma membrane permeability and causing bacterial DNA destruction, and it effectively inhibits the formation of bacterial biofilms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ruppia maritima extract.